Results 171 to 180 of about 8,384 (230)

Challenges for gene therapy in the financial sustainability of health systems: a scoping review. [PDF]

Orphanet J Rare Dis
Ossandon H, Armijo N, Vargas C, Repetto GM, Espinoza MA.   +4 more
europepmc   +1 more source

How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective. [PDF]

Int J Technol Assess Health Care
Espinosa O, Drummond M, Russo E, Williams D, Wix D.   +4 more
europepmc   +1 more source

Financing costs and the competitiveness of renewable power. [PDF]

iScience
Wilson C, Shrimali G, Caldecott B.
europepmc   +1 more source

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy. [PDF]

Cureus
Duesberg MS, Schiller G.
europepmc   +1 more source

Artificial Intelligence and the Transformation of Cell and Gene Therapy Development. [PDF]

Pharmaceutics
Auclair JR, Joung J, Singh MA, Debauve G, Singh R.   +4 more
europepmc   +1 more source

A budget impact analysis of gene therapy for sickle cell disease: an updated analysis. [PDF]

Blood Adv
DeMartino PC, Haag MB, Caughey AB, Roth JA.   +3 more
europepmc   +1 more source

Body composition in early pubescent children with obesity: effects following 1 year of nonintervention.

J Appl Physiol (1985)
Babb TG, Wilhite DP, Martinez-Fernandez T, Liu Y, Gupta OT, Barlow S, Bhammar DM.   +6 more
europepmc   +1 more source

Annuity market imperfections.

Sanders, E.A.T.
core